Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

Damien Marsic, Ph.D.

Porton Advanced Solutions

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Cell and Gene Therapy Analytics

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

Hui Chen, Ph.D.

Porton Advanced Solutions